Skip to main content
Back to Global Brain Corporation

Global Brain Corporation's Biotechnology Portfolio

Browse 9 Biotechnology companies funded by Global Brain Corporation. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
9
Total Funding in Biotechnology
$166.5M

Biotechnology Portfolio Companies (9)

Export
AnalyticsBiotechnologyLife ScienceMedical

BitBiome sequences microbial genomes to support health research and improve biomanufacturing and industrial biotechnology processes.

Tokyo, Japan
May 2026
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareNeuroscienceTherapeutics

Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.

Boston, United States
March 2026
$3.3M
Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine Learning

Persist AI is a biotechnology company that builds long-acting microsphere formulations.

Woodland, United States
March 2025
$12.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

ChromaCode is a molecular diagnostics company focusing on bioinformatics.

Carlsbad, United States
February 2025
$3.8M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyManufacturingMedicalRental

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

Kyoto, Japan
October 2024
$15.2M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Boston, United States
September 2024
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

AgricultureBiotechnologyChemicalGeneticsLife ScienceManufacturing

Ac-Planta is an agri-biotech company that develops, manufactures, and sells biostimulant materials.

Tokyo, Japan
March 2024
$3.2M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

San Carlos, United States
March 2024
$12.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Switch Therapeutics is a biotech company that develops RNAi therapies.

San Francisco, United States
March 2023
$52.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore Global Brain Corporation's Full Portfolio

View all companies funded by Global Brain Corporation across every industry and funding stage.

View Full Global Brain Corporation Portfolio